全文获取类型
收费全文 | 4176篇 |
免费 | 296篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 108篇 |
妇产科学 | 93篇 |
基础医学 | 611篇 |
口腔科学 | 41篇 |
临床医学 | 317篇 |
内科学 | 1169篇 |
皮肤病学 | 294篇 |
神经病学 | 536篇 |
特种医学 | 77篇 |
外科学 | 314篇 |
综合类 | 5篇 |
预防医学 | 220篇 |
眼科学 | 31篇 |
药学 | 252篇 |
中国医学 | 6篇 |
肿瘤学 | 415篇 |
出版年
2024年 | 12篇 |
2023年 | 55篇 |
2022年 | 98篇 |
2021年 | 179篇 |
2020年 | 121篇 |
2019年 | 132篇 |
2018年 | 137篇 |
2017年 | 117篇 |
2016年 | 141篇 |
2015年 | 170篇 |
2014年 | 217篇 |
2013年 | 244篇 |
2012年 | 342篇 |
2011年 | 337篇 |
2010年 | 161篇 |
2009年 | 189篇 |
2008年 | 260篇 |
2007年 | 256篇 |
2006年 | 233篇 |
2005年 | 225篇 |
2004年 | 201篇 |
2003年 | 200篇 |
2002年 | 159篇 |
2001年 | 31篇 |
2000年 | 26篇 |
1999年 | 27篇 |
1998年 | 40篇 |
1997年 | 17篇 |
1996年 | 15篇 |
1995年 | 21篇 |
1994年 | 22篇 |
1993年 | 11篇 |
1992年 | 12篇 |
1991年 | 14篇 |
1990年 | 15篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 14篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 5篇 |
1973年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有4515条查询结果,搜索用时 15 毫秒
131.
Cataldo Patruno Luca Stingeni Katharina Hansel Silvia Mariel Ferrucci Simona Tavecchio Gabriella Fabbrocini Steven Paul Nistic Caterina Foti Serena De Prezzo Maddalena Napolitano 《Dermatologic therapy》2020,33(3)
Nummular eczema (NE) is currently considered as one of the clinical phenotypes of atopic dermatitis (AD) of the adult. In this multicentre study, 30 adult patients (age ≥ 18 years) affected with nummular‐like AD were treated with dupilumab, a monoclonal antibody against the receptor for interleukin(IL)‐4 and IL‐13. The evaluation of the results after 16 weeks of treatment showed a significant improvement of the disease, as demonstrated by reduction in Eczema Area Severity Score (EASI), visual analogue score (VAS) of pruritus, and Dermatology Life Quality Index (DLQI) scores. Conjunctivitis in one patient was the only side effect. In conclusion, dupilumab seems to be an effective and safe treatment in NE phenotype of AD of the adult. 相似文献
132.
Claudio Conforti Roberta Giuffrida Nicola Di Meo Michela Longone Silvia Vichi Claudia Colli Teresa Deinlein Roberta Vezzoni Chiara Retrosi Enzo Errichetti Serafinella Patrizia Cannav Iris Zalaudek Caterina Dianzani 《Dermatologic therapy》2020,33(3)
The male genitalia are a common site of dermatoses. Patients with penile diseases often delay or avoid medical care due to anxiety and embarrassment. In this narrative review, we describe some of the main benign dermatoses localized to male genital, focusing on their epidemiology, clinical and dermoscopic features, as well as available therapies. 相似文献
133.
Thais Basili Higinio Dopeso Sarah H. Kim Lorenzo Ferrando Fresia Pareja Arnaud Da Cruz Paula Edaise M. da Silva Anthe Stylianou Ana Maroldi Caterina Marchiò Brian P. Rubin Mauro Papotti Britta Weigelt Carlos Gil Moreira Ferreira José Roberto Lapa e Silva Jorge S. Reis-Filho 《International journal of cancer. Journal international du cancer》2020,147(8):2253-2264
Hyalinizing trabecular tumors of the thyroid are rare and mostly benign epithelial neoplasms of follicular cell origin, which have recently been shown to be underpinned by the PAX8-GLIS3 fusion gene. In our study, we sought to investigate the potential oncogenic mechanisms of the PAX8-GLIS3 fusion gene. Forced expression of PAX8-GLIS3 was found to increase proliferation, clonogenic potential and migration of human nonmalignant thyroid (Nthy-ori 3-1) and embryonic kidney (HEK-293) cells. Moreover, in xenografts, Nthy-ori 3-1 PAX8-GLIS3 expressing cells generated significantly larger and more proliferative tumors compared to controls. These oncogenic effects were found to be mediated through activation of the Sonic Hedgehog (SHH) pathway. Targeting of smoothened (SMO), a key protein in the SHH pathway, using the small molecule inhibitor Cyclopamine partially reversed the increased proliferation, colony formation and migration in PAX8-GLIS3 expressing cells. Our data demonstrate that the oncogenic effects of the PAX8-GLIS3 fusion gene are, at least in part, due to an increased activation of the SHH pathway. 相似文献
134.
Nouchine Hadjikhani MD PhD Daniel S. Albrecht PhD Caterina Mainero MD PhD Eri Ichijo MS Noreen Ward MS Cristina Granziera MD PhD Nicole R. Zürcher PhD Oluwaseun Akeju MD Guillaume Bonnier PhD Julie Price PhD Jacob M. Hooker PhD Vitaly Napadow PhD Matthias Nahrendorf MD PhD Marco L. Loggia PhD Michael A. Moskowitz MD 《Annals of neurology》2020,87(6):939-949
135.
136.
Simonetta Viviani Arabella Mazzocchi Chiara Pavoni Francesca Taverna Andrea Rossi Caterina Patti Alessandra Romano Livio Trentin Roberto Sorasio Anna Guidetti Daniela Gottardi Corrado Tarella Michele Cimminiello Roberta Zanotti Lucia Farina Andrés José Maria Ferreri Marina Galbiati Paolo Corradini Alessandro Massimo Gianni Andrea Gallamini Alessandro Rambaldi 《Hematological oncology》2020,38(4):501-508
Among patients with advanced-stage classical Hodgkin lymphoma (cHL) receiving ABVD chemotherapy, PET performed after the first two treatment cycles (PET-2) has prognostic value. However, 15% of patients with a negative PET-2 will experience treatment failure. Here we prospectively evaluated serum thymus and activation-regulated chemokine (TARC) levels, to improve risk assessment in patients treated according to HD0607 PET-driven trial (#NCT00795613). In 266 patients with available serum samples, who have agreed to participate in a sub-study for assessment of the role of TARC monitoring, serum TARC levels were measured at baseline and at time of PET-2 by commercially available ELISA test kits. The primary end-point was to evaluate the association between TARC after 2 ABVD cycles and PFS. Median TARC-2 values were significantly higher in PET-2-positive patients compared to PET-2-negative patients (P = .001), and in patients with treatment failure compared to those in continuous CR (P = .01). The 4-year PFS significantly differed between patients with TARC-2 >800 pg/mL vs ≤800 pg/mL (64% vs 86%, P = .0001). Moreover, among PET-2-negative patients, elevated TARC-2 identified those with a worse prognosis (74% vs 89%; P = .01). In multivariable analysis, TARC-2 >800 pg/mL was a significant independent predictor of PFS in the whole study population (HR 2.39, P = .004) and among the PET-2-negative patients (HR 2.49, P = .02). In conclusion, our results indicate that TARC-2 serum levels above 800 pg/mL suggest the need for a stringent follow-up in PET-2-negative patients, and the evaluation of new drugs in PET-2-positive, who will likely fail to respond to intensification with escalated BEACOPP. 相似文献
137.
138.
Daniela Di Girolamo Raffaele Ambrosio Maria A. De Stefano Giuseppina Mancino Tommaso Porcelli Cristina Luongo Emery Di Cicco Giulia Scalia Luigi Del Vecchio Annamaria Colao Andrzej A. Dlugosz Caterina Missero Domenico Salvatore Monica Dentice 《The Journal of clinical investigation》2016,126(6):2308-2320
139.
Francesca Margheri Laura Maggi Alessio Biagioni Anastasia Chillà Anna Laurenzana Francesca Bianchini Daniele Bani Manuela Capone Alessio Mazzoni Maria Caterina Rossi Francesco Liotta Lorenzo Cosmi Teresa Giani Rolando Cimaz Gabriella Fibbi Francesco Annunziato Mario Del Rosso 《European journal of immunology》2021,51(1):220-230
How T-helper (Th) lymphocyte subpopulations identified in synovial fluid from patients with juvenile idiopathic arthritis (JIA) (Th17, classic Th1, or nonclassic Th1) drive joint damage is of great interest for the possible use of biological drugs that inhibit the specific cytokines. Our objective was to clarify the role of such Th subpopulations in the pathogenesis of articular cartilage destruction by synovial fibroblasts (SFbs), and the effect of Th17 blockage in an animal model. SFbs were isolated from healthy subjects and patients with JIA, and peripheral blood Th lymphocytes subsets were obtained from healthy subjects. Fragments of human cartilage from healthy subjects in a collagen matrix containing JIA or normal SFbs grafted underskin in SCID mice were used to measure cartilage degradation under the effects of Th supernatants. JIA SFbs overexpress MMP9 and MMP2 and Th17 induce both MMPs in normal SFbs, while nonclassic Th1 upregulate urokinase plasminogen activator (uPA) activity. In vitro invasive phenotype of normal SFbs is stimulated with conditioned medium of Th17 and nonclassic-Th1. In the in vivo “inverse wrap” model, normal SFbs stimulated with supernatants of Th17-lymphocytes and nonclassic Th1 produced a cartilage invasion and degradation similar to JIA SFbs. Secukinumab inhibits the cartilage damage triggered by factors produced by Th17. 相似文献
140.
Is the prevalence of hidradenitis suppurativa being overestimated in Europe? Or is the disease underdiagnosed? Evidence from a nationwide study across Portuguese public hospitals 下载免费PDF全文